CEREMED, INC. – Trademark Portfolio

Entity Type: 03

CEREMED, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AOC, OSTENE, and CEREMED. The owner is based in LOS ANGELES, CA.

3643 LENAWEE AVE.

LOS ANGELES, CA 90016

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OSTENE
OSTENE
Registered 2005
CEREMED
CEREMED
Registered 2004
AOC
AOC
Registered 2004
OSTEOPOR
OSTEOPOR
Cancelled 1999
BIOPOR
BIOPOR
Cancelled 1999

Trademark Classifications

CEREMED, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CEREMED, INC. have?

CEREMED, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.

What trademark classes does CEREMED, INC. file in?

CEREMED, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CEREMED, INC.'s most well-known trademarks?

CEREMED, INC.'s registered trademark portfolio includes well-known marks such as AOC, OSTENE, and CEREMED. These are among 3 currently registered trademarks in the portfolio.

What is CEREMED, INC.'s trademark registration success rate?

CEREMED, INC. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.